Selective and Reliable Fluorometric Quantitation of Anti-cancer Drug in Real Plasma Samples Using Nitrogen-doped Carbon Dots After MMIPs Solid Phase Microextraction: Monitoring Methotrexate Plasma Level
Overview
Authors
Affiliations
A novel selective and reliable ratiometric fluorescence probe has been successfully synthesized for precise, sensitive, and simple quantitation of methotrexate (MTX). Hydrothermal method was employed to fabricate nitrogen-doped carbon dots using Annona squamosa seeds (AS-CDs) as a starting material, and their characteristics were confirmed using transmission electron microscopy (TEM), UV-Vis spectroscopy, fluorescence spectroscopy, X-ray diffractometry (XRD), and Fourier Transform Infrared Spectroscopy (FTIR). The ratiometric fluorometric assay, which is based on measuring the ratio of emissions (F/F), has a wide detection range of 5-2000 ng /mL and a limit of detection (LOD, S/N = 3) of 1.5 ng /mL. The developed sensing method was successfully applied to the quantification of MTX in rabbit plasma samples and parenteral formulations, achieving satisfactory recoveries %. Magnetic molecularly imprinted solid-phase microextraction was used for selective extraction of MTX from plasma samples. The pharmacokinetic parameters were successfully determined in real rabbit plasma samples after intravenous administration of MTX. The as-designed probe does not only improve the sensitivity, but also enhances the precision and accuracy of the proposed method. Overall, this study presents a promising approach for the detection of MTX in genuine samples with acceptable degree of selectivity and sensitivity.
Yan J, Liu S, Sun D, Peng S, Ming Y, Ostovan A Sensors (Basel). 2024; 24(21).
PMID: 39517965 PMC: 11548425. DOI: 10.3390/s24217068.
Mahmoud A, Alqahtani Y, El-Wekil M, Ali A J Fluoresc. 2024; .
PMID: 38691279 DOI: 10.1007/s10895-024-03737-2.
Cobalt-modulated dual emission carbon dots for ratiometric fluorescent vancomycin detection.
Alhazzani K, Alanazi A, Mostafa A, Barker J, El-Wekil M, Ali A RSC Adv. 2024; 14(8):5609-5616.
PMID: 38357036 PMC: 10865304. DOI: 10.1039/d3ra08899e.
Alhazzani K, Alanazi A, Mostafa A, Barker J, El-Wekil M, Ali A RSC Adv. 2024; 14(4):2380-2390.
PMID: 38213979 PMC: 10783161. DOI: 10.1039/d3ra07844b.